Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 46 min 1 sec ago

Lumara Health(TM) to be Acquired in Two Separate Transactions for up to $1.107 Billion

Mon, 09/29/2014 - 15:42
AMAG Pharmaceuticals, Inc. to Acquire Lumara Health Perrigo Company to Acquire the Women's Healthcare Assets ST. LOUIS, Sept. 29, 2014 -- (Healthcare Sales & Marketing Network) -- Lumara Health™ today announced that it has entered into two separate ...
Biopharmaceuticals, Mergers & Acquisitions
Lumara Health, AMAG Pharmaceuticals, Perrigo Company

AMAG Pharmaceuticals to Acquire Lumara Health Maternal Health Business

Mon, 09/29/2014 - 15:37
Accelerates transformation of AMAG to a Profitable, Multi-Product Specialty Pharmaceutical Company Adds FDA-Approved Therapy Makena(R) and Complementary Commercial Platform to AMAG Portfolio Projected Pro Forma Combined 2015 Revenues of $350 million ...
Biopharmaceuticals, Mergers & Acquisitions
AMAG Pharmaceuticals, Lumara Health, Makena, hydroxyprogesterone

Navidea’s Lymphoseek(R) Recommended by CHMP for European Approval in Sentinel Lymph Node Detection for Melanoma, Breast and Certain Head and Neck Cancers

Fri, 09/26/2014 - 13:21
Following European Commission authorization, Lymphoseek (technetium Tc 99m tilmanocept) Injection will be the first approved Sentinel Lymph Node detection agent in the EU DUBLIN, Ohio--(Healthcare Sales & Marketing Network)--Navidea Biopharmaceuticals, ...
Biopharmaceuticals, Oncology, Regulatory
Navidea Biopharmaceuticals, Lymphoseek, tilmanocept, sentinel lymph node

AcelRx Pharmaceuticals Provides Regulatory Update on Zalviso(TM)

Fri, 09/26/2014 - 13:12
REDWOOD CITY, Calif., Sept. 26, 2014 -- (Healthcare Sales & Marketing Network) -- AcelRx Pharmaceuticals, Inc. (ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute a...
Biopharmaceuticals, FDA
AcelRx Pharmaceuticals, Zalviso, sufentanil, sublingual

Biota Pharmaceuticals Announces Changes to Management and Board of Directors

Fri, 09/26/2014 - 13:06
ATLANTA, Sept. 26, 2014 -- (Healthcare Sales & Marketing Network) -- Biota Pharmaceuticals, Inc. (BOTA) (the "Company") today announced a number of changes to management and its board of directors that will become effective October 1, 2014. Th...
Biopharmaceuticals, Personnel
Biota Pharmaceuticals

Sumitomo Dainippon Pharma and SanBio Conclude Joint Development and License Agreement for North America over SB623, Therapy for Stroke

Fri, 09/26/2014 - 12:58
OSAKA, Japan, Sept. 26, 2014 -- (Healthcare Sales & Marketing Network) -- Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon Pharma") and SanBio Co., Ltd., acting through its U.S. subsidiary SanBio, Inc. ("SanBio"), announced on ...
Biopharmaceuticals, Neurology, Licensing
Sumitomo Dainippon Pharma, SanBio Co, SB623, cell therapy, stroke

ReFlow Medical Corporation Announces CE Mark and Initial Clinical Use of the Wingman35 Crossing Catheter and SpeX(TM) Shapeable Support Catheter

Thu, 09/25/2014 - 15:59
SAN CLEMENTE, Calif.--(Healthcare Sales & Marketing Network)--ReFlow Medical, Inc. (ReFlow) today announced the initial clinical use of their Wingman35 Crossing Catheter and speX™ Shapeable Support Catheter by Dr. Andrej Schmidt at University Leipzig, Germ...
Devices, Interventional, Regulatory
ReFlow Medical, Wingman35, Crossing Catheter

IGI Laboratories, Inc. Acquires Eighteen Former Products From AstraZeneca

Thu, 09/25/2014 - 15:54
BUENA, N.J., Sept. 25, 2014 -- (Healthcare Sales & Marketing Network) -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has acquired the regulatory rights and related documents and re...
Biopharmaceuticals, Acquisitions
IGI Laboratories, AstraZeneca

Cook Group Incorporated Promotes Connie Jackson to Senior Vice President, Human Resources

Thu, 09/25/2014 - 15:51
BLOOMINGTON, Ind.--(Healthcare Sales & Marketing Network)--Connie Jackson, who has served as global vice president of human resources since 2005, has been promoted to senior vice president of human resources, the company said today. As senior vice presiden...
Devices, Personnel
Cook Medical

Jeffrey W. Ubben, CEO Of ValueAct Capital, Appointed To The Board Of Valeant Pharmaceuticals

Thu, 09/25/2014 - 15:49
LAVAL, Quebec, Sept. 25, 2014 -- (Healthcare Sales & Marketing Network) -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today announced that its Board of Directors has appointed Jeffrey W. Ubben, Founder, Chief Executive Officer, and the Ch...
Biopharmaceuticals, Dermatology, Personnel
Valeant Pharmaceuticals

Zyga Technology Completes $10 Million Financing

Thu, 09/25/2014 - 15:47
MINNETONKA, Minn., Sept. 25, 2014 -- (Healthcare Sales & Marketing Network) -- Zyga Technology, Inc., a developer of minimally invasive solutions for underserved areas in spine, announced today that it has completed a $10 million round of financing. The c...
Devices, Orthopaedic, Neurosurgery, Venture Capital
Zyga Technology, SImmetry, Sacroiliac Joint Fusion, Glyder, Facet Restoration

LabCorp Announces Agreement to Acquire LipoScience

Thu, 09/25/2014 - 15:42
Acquisition Price of $5.25 Per Share in All Cash Transaction NMR LipoProfile test expands LabCorp’s offering of personalized diagnostic tests BURLINGTON, N.C.--(Healthcare Sales & Marketing Network)--Laboratory Corporation of America® Holdings (L...
Diagnostics, Personalized Medicine, Mergers & Acquisitions
Laboratory Corporation of America, LabCorp, LipoScience

Innovus Pharma Signs License Agreement With Sothema Laboratories for Zestra(R) and Zestra Glide(R) in the Middle East (Excluding Lebanon and Israel), North Africa and West Africa

Wed, 09/24/2014 - 13:04
Innovus Eligible to Receive Upfront and Up to $171.25 Million U.S. in Sales Milestone Payments Plus Transfer Price SAN DIEGO, Sept. 24, 2014 -- (Healthcare Sales & Marketing Network) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma") www.inn...
Biopharmaceuticals, Licensing
Innovus Pharmaceuticals, Sothema Laboratories, Zestra, Zestra Glide

MediValve, Ltd. Announces Initiation of post-Market Clinical Evaluations of the acWire(TM) Guidewire at Lenox Hill Hospital (New York)

Wed, 09/24/2014 - 12:53
KIBBUTZ HAMA'APIL, Israel, September 24, 2014 -- (Healthcare Sales & Marketing Network) --The acWire™ is intended for use in peripheral vascular and heart catheterization procedures to introduce and assist in positioning diagnostic and interventional devi...
Devices, Interventional
MediValve , acWire , Guidewire

Catheter Connections Fails Disinfection Test on Second Common Bacteria, Announces Ivera Medical

Wed, 09/24/2014 - 12:47
SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - Ivera Medical announced that an independent lab has found that the dark blue IV-Pole Strips and DualCap products for male luer connectors made by Catheter Connections failed to disinfect all critical ...
Devices
Ivera Medical, Catheter Connections

Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development

Tue, 09/23/2014 - 12:35
PRINCETON, N.J., Sept. 23, 2014 -- (Healthcare Sales & Marketing Network) -- Soligenix, Inc. (SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncol...
Biopharmaceuticals, Personnel
Soligenix

Ivantis Raises Additional $25 MM, Increasing Series B to $71 MM

Tue, 09/23/2014 - 12:31
Funds will support multiple clinical trials, including ongoing U.S. pivotal trial for novel glaucoma device IRVINE, Calif.--(Healthcare Sales & Marketing Network)--Ivantis, developer of the novel Hydrus Microstent device designed to lower eye pressure f...
Devices, Ophthalmology, Venture Capital
Ivantis, Hydrus Microstent, glaucoma

Thoratec Appoints D. Keith Grossman President And Chief Executive Officer

Mon, 09/22/2014 - 13:45
PLEASANTON, Calif., Sept. 22, 2014 -- (Healthcare Sales & Marketing Network) -- Thoratec Corporation (THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that D. Keith...
Devices, Cardiology, Personnel
Thoratec, HeartMate, Ventricular Assist Device

Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer

Mon, 09/22/2014 - 13:38
Focus on Commercial Readiness and Global Operations LEXINGTON, Mass., Sept. 22, 2014 -- (Healthcare Sales & Marketing Network) -- Synageva BioPharma Corp. ("Synageva") (GEVA), a biopharmaceutical company developing therapeutic products for ra...
Biopharmaceuticals, Personnel
Synageva BioPharma

Innovus Pharma Signs License Agreement With Orimed Pharma for Zestra(R), EjectDelay(TM), Sensum+(TM) and Zestra Glide(R) in Canada

Mon, 09/22/2014 - 13:29
Innovus Eligible to Receive Up to $94.5 Million CAD in Upfront and Sales Milestone Payments Plus Double-Digit Tiered Royalties SAN DIEGO, Sept. 22, 2014 -- (Healthcare Sales & Marketing Network) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma&qu...
Biopharmaceuticals, Licensing
Innovus Pharmaceuticals, Orimed Pharma, Zestra, EjectDelay, Sensum+

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong